首页> 外文期刊>Journal of Medicinal Chemistry >Selective, high affinity peptide antagonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro.
【24h】

Selective, high affinity peptide antagonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro.

机译:选择性,高亲和力的α-促黑素对人类黑皮质素受体4的作用的肽拮抗剂:它们的合成和体外生物学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Peptide Ac-Nle(4)-cyclo(5beta-->10epsilon)(Asp(5)-His(6)-D-(2')Nal(7)-Arg(8)-Trp(9 )-Lys(10))-NH(2), compound 1, a cyclic derivative of alpha-melanotropin, is a nonselective high affinity antagonist at human melanocortin receptors 3 and 4, and an agonist at melanocortin receptors 1 and 5. To differentiate between the physiological functions of these receptors, antagonists with improved receptor selectivity are needed. In this study, analogues of compound 1 without Ac-Nle(4) or His(6) and/or the amino group of Asp(5) were prepared and tested in binding assays and in functional assays on CHO cells expressing hMC3-5R. Several of these peptides were to be selective, high affinity hMC-4R antagonists. The most interesting was compound 10, named MBP10, cyclo(6beta-->10epsilon)(succinyl(6)-D-(2')Nal(7)-Arg(8)-Trp(9)-Lys(10))-N H(2), an antagonist (IC(50) = 0.5 nM) with 125-fold selectivity over hMC-3R (and of >300-fold selectivity over MC-1RB). This compound had no agonist activity at hMC-3R or hMC-4R and only weak agonist activity at hMC-5R. Examination of the sequences of these new peptides revealed that the D-(2')Nal(7)-Arg(8)-Trp(9) segment of peptide 1 forms the "essential core" required for high affinity and high selectivity of analogues of peptide 1 at hMC-4R, but the "extended core", His(6)-D-(2')Nal(7)-Arg(8)-Trp(9), is necessary for the maximum affinity for hMC-3R and hMC-5R.
机译:肽Ac-Nle(4)-cyclo(5beta-> 10epsilon)(Asp(5)-His(6)-D-(2')Nal(7)-Arg(8)-Trp(9)-Lys( 10))-NH(2),化合物1,α-黑素皮质激素的环状衍生物,是人类黑皮质素受体3和4的非选择性高亲和力拮抗剂,是黑皮质素受体1和5的激动剂。以区分生理功能在这些受体中,需要具有改善的受体选择性的拮抗剂。在这项研究中,制备了不含Ac-Nle(4)或His(6)和/或Asp(5)氨基的化合物1的类似物,并在表达hMC3-5R的CHO细胞的结合测定和功能测定中进行了测试。这些肽中的几种是选择性的,高亲和力的hMC-4R拮抗剂。最有趣的是化合物10,名为MBP10,环(6beta-> 10epsilon)(琥珀酰(6)-D-(2')Nal(7)-Arg(8)-Trp(9)-Lys(10)) -NH(2),一种拮抗剂(IC(50)= 0.5 nM),其选择性比hMC-3R高125倍(并且比MC-1RB高300倍)。该化合物对hMC-3R或hMC-4R没有激动剂活性,而对hMC-5R只有弱的激动剂活性。对这些新肽的序列的研究表明,肽1的D-(2')Nal(7)-Arg(8)-Trp(9)片段形成了类似物的高亲和力和高选择性所需的“基本核心” hMC-4R上肽1的片段,但“扩展核心” His(6)-D-(2')Nal(7)-Arg(8)-Trp(9)对于最大的hMC-亲和力是必需的3R和hMC-5R。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号